Patents by Inventor Soliman Khatib

Soliman Khatib has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Publication number: 20230202967
    Abstract: The present invention relates to lyso-diacylglyceryltrimethylhomoserine (lyso- DGTS) or derivatives thereof for use in the treatment of atherosclerotic cardiovascular disease, and further provides particular such lyso-DGTS derivatives.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 29, 2023
    Applicant: GAVISH-GALILEE BIO APPLICATIONS LTD.
    Inventors: Jacob VAYA, Soliman KHATIB, Emma KVITNITSKY
  • Compositions and methods for treating atherosclerotic cardiovascular disease
    Patent number: 11591288
    Abstract: The present invention relates to lyso-diacylglyceryltrimethylhomoserine (lyso-DGTS) or derivatives thereof for use in the treatment of atherosclerotic cardiovascular disease, and further provides particular such lyso-DGTS derivatives.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: February 28, 2023
    Assignee: GAVISH-GALILEE BIO APPLICATIONS LTD.
    Inventors: Jacob Vaya, Soliman Khatib, Emma Kvitnitsky
  • PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT
    Publication number: 20210023217
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Application
    Filed: October 11, 2020
    Publication date: January 28, 2021
    Inventors: Jacob PITCOVSKI, Jacob VAYA, Soliman KHATIB, Elina AIZENSHTEIN, Tal GEFEN
  • Proteins modified with (amino) monosaccharide-biotin adduct
    Patent number: 10821179
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: November 3, 2020
    Assignee: GAVISH-GALILEE BIO APPLICATIONS, LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Elina Aizenshtein, Tal Gefen
  • COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Publication number: 20200308100
    Abstract: The present invention relates to lyso-diacylglyceryltrimethylhomoserine (lyso-DGTS) or derivatives thereof for use in the treatment of atherosclerotic cardiovascular disease, and further provides particular such lyso-DGTS derivatives.
    Type: Application
    Filed: August 22, 2018
    Publication date: October 1, 2020
    Inventors: Jacob VAYA, Soliman KHATIB, Emma KVITNITSKY
  • PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT
    Publication number: 20160120977
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Application
    Filed: November 4, 2015
    Publication date: May 5, 2016
    Applicant: GAVISH-GALILEE BIO APPLICATIONS, LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Elina Aizenshtein, Tal Gefen
  • PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT
    Publication number: 20120156227
    Abstract: A protein covalently linked to, or coated with, a non-immunogenic molecule selected from an amino monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immuno-genicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination
    Type: Application
    Filed: June 6, 2010
    Publication date: June 21, 2012
    Applicant: GAVISH-GALILEE BIO APPLICATIONS LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Alina Aizenshtein, Tal Gefen